Aplicación YC de AesculaTech
AesculaTech pasó por Y Combinator en el batch Winter 2018 como una empresa de Healthcare. Abajo: qué hace la empresa, quién la fundó y su aplicación a YC, reconstruida pregunta por pregunta en el formulario real de YC.
- Batch YC
- Winter 2018
- Industria
- HealthcareMedical Devices
- Tamaño del equipo
- 6
- Estado
- Active
- Lanzado
- 2017
Fundadores
Niki BayatFounder/CEO
Lo que hace AesculaTech
AesculaTech believes in building better lives through smart chemistry. We design custom smart materials for a range of biomedical, commercial, and industrial applications. Our platform technology, AesculaGel offers adaptive response to a wide range of stimuli and can be tailor-made for biocompatibility, material strength, and a range of other attributes. Founded by one of MIT's 35 under 35 Innovators, AesculaTech is the shared vision of scientists, engineers, and medical experts. Our cornerstone product, Humidifeye, is an ophthalmic platform to treat dry eye disease. Dry eye affects more than 25 million Americans and the global treatment market is projected higher than $6 Billion within the next decade. Our thermally responsive, form-fitting materials are suitable for sustained yet reversible occlusion across a range of treatment times. In contrast to existing technologies, our product will not extrude, or cause discomfort as it adapts to patients. Though Humidifeye is not yet FDA approved, expect to hear about it soon! In coordination with partners across several sectors, we have a variety of groundbreaking technologies in the works that live up to our vision. This work has already been recognized. AesculaTech was named a Rosenman Innovator, received a National Science Foundation I-Corps grant, was a finalist in the 2019 Octane High Tech Awards, and is a graduate of both the Y Combinator and TMCx accelerator programs. In short, Y-Combinator was only the beginning.
Aplicación YC de AesculaTech, reconstruida
Solicitud de Y Combinator
AesculaTech, batch Winter 2018. Las preguntas reales del formulario, respondidas con datos públicos.
- Founders2
- Company7
- Progress7
- Idea4
- Equity3
- Curious2
- Batch Preference1
Company
AesculaTech
Responsive materials, better lives.
We make AesculaGel, a smart, adaptive material platform that responds to stimuli and can be tailor-made for strength and biocompatibility. Our lead product, Humidifeye, uses these materials for sustained, comfortable treatment of dry eye disease by providing thermally responsive, form-fitting occlusion that adapts to patients instead of causing discomfort or extrusion like current options.
We live in Los Angeles, CA, and we would continue to be based here after YC.
Los Angeles is our home base with access to local medical experts and manufacturing partners. Staying here keeps our team close and connected to the relevant biomedical ecosystem.
21 respuestas más en la aplicación completa
están en la versión completa. Crea una cuenta gratuita para abrirla en YC Insights, junto a cada otro batch de YC.
Preguntas Frecuentes
¿Es esta la aplicación YC real de AesculaTech?
No. Y Combinator mantiene privadas las aplicaciones enviadas. Esta es una reconstrucción: las preguntas reales del formulario de YC, respondidas a partir de los datos públicos de AesculaTech (notas de lanzamiento, antecedentes de fundadores, descripción del producto). Muestra cómo una empresa como AesculaTech se presentaría a YC, no el texto que enviaron.
¿En qué batch de YC estuvo AesculaTech?
AesculaTech formó parte del batch Winter 2018 de Y Combinator.
¿Quién fundó AesculaTech?
AesculaTech fue fundado por Niki Bayat.
¿A qué se dedica AesculaTech?
Responsive materials, better lives.
¿Cómo leo la aplicación completa reconstruida?
Crea una cuenta gratuita de Round Funded. La versión completa de 26 respuestas de la aplicación de AesculaTech, y de cada otro batch de YC, está en YC Insights.
Más startups de YC como AesculaTech
